This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "20160811 sdwg agenda"

From HL7Wiki
Jump to navigation Jump to search
 
Line 47: Line 47:
 
#*CDA/C-CDA on FHIR
 
#*CDA/C-CDA on FHIR
 
#Clinical Oncology Treatment Plan and Summary (Jeff)
 
#Clinical Oncology Treatment Plan and Summary (Jeff)
#Referral Note - Have we considered including an 'Authorization number' and 'Referral Order number' in the Referral Note?
+
#C-CDA Support Items
#Branch validation - how do we identify a branch?
+
#*Referral Note - Have we considered including an 'Authorization number' and 'Referral Order number' in the Referral Note?
 +
#*Inpatient vs outpatient medications?
 +
#*Branch validation - how do we identify a branch?
 
#Adjournment
 
#Adjournment
  
 
[[Category:SDWG Agendas]]
 
[[Category:SDWG Agendas]]

Latest revision as of 00:29, 11 August 2016

SDWG - Meeting

Teleconferences are generally held on Thursday at 10:00am - 12:00 pm U.S. Eastern. Schedules may be found at HL7.org Conference Call Center

SDWG now uses a webinar service for its main conference calls. You will need to register in advance for the webinar: SDWG Goto Meeting.

Conference call: Dial 770-657-9270 Passcode #310940

Link to SDWG Teleconference Page

If you have trouble getting on the SDWG conference line please log a ticket Conference Call Problems

Agenda

  1. Call to order
  2. Business Updates (10 min)
    • Additions/modifications to the agenda
    • HL7
      • RIM (AKreisler)
      • Steering Division / TSC (CBeebe)
      • Vocab (RHausam)
      • Pub facilitator (AHenket)
      • Electronic Services and Tools (JBrown)
      • Patient Care (LNelson)
      • Example Task Force (Brett)
  3. External Initiative Updates
    • Electronic Submission of Medical Documentation (eSMD)
    • Clinical Quality Framework (CQF)
    • Data Access Framework (DAF)
    • Other S&I initiative updates (eLTSS, etc.)
  4. Project Updates
    • CDA R2.1
    • Clinical Guidance for Relevant and Pertinent for Generated Documents - work group planning (David)
    • DSTU comments on C-CDA R1.1/R2.1
    • C-CDA Companion Guide
    • C-CDA value set review
    • CDA/C-CDA on FHIR
  5. Clinical Oncology Treatment Plan and Summary (Jeff)
  6. C-CDA Support Items
    • Referral Note - Have we considered including an 'Authorization number' and 'Referral Order number' in the Referral Note?
    • Inpatient vs outpatient medications?
    • Branch validation - how do we identify a branch?
  7. Adjournment